CP
CVS icon

Cumberland Partners’s CVS Health CVS Stock Holding History

Cumberland Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-29,150
Closed -$1.83M – 176
2024
Q3 		$1.83M Sell
29,150
-1,245
-4% -$72.6K 0.13% 102
2024
Q2 		$1.8M Sell
30,395
-4,074
-12% -$255K 0.13% 100
2024
Q1 		$2.75M Sell
34,469
-1,941
-5% -$148K 0.2% 81
2023
Q4 		$2.54M Sell
36,410
-945
-3% -$67.3K 0.23% 76
2023
Q3 		$2.61M Buy
37,355
+5,770
+18% +$409K 0.25% 77
2023
Q2 		$2.18M Sell
31,585
-4,575
-13% -$326K 0.2% 89
2023
Q1 		$2.69M Buy
36,160
+6,850
+23% +$574K 0.26% 73
2022
Q4 		$2.73M Sell
29,310
-6,340
-18% -$612K 0.29% 70
2022
Q3 		$3.4M Sell
35,650
-17,725
-33% -$1.75M 0.36% 57
2022
Q2 		$4.95M Sell
53,375
-48,435
-48% -$4.73M 0.47% 48
2022
Q1 		$10.3M Sell
101,810
-41,085
-29% -$4.32M 0.78% 37
2021
Q4 		$14.7M Sell
142,895
-11,145
-7% -$1.03M 1.04% 30
2021
Q3 		$13.1M Sell
154,040
-1,153
-0.7% -$96.6K 1.07% 29
2021
Q2 		$12.9M Sell
155,193
-4,732
-3% -$388K 1.02% 32
2021
Q1 		$12M Sell
159,925
-7,475
-4% -$544K 0.99% 32
2020
Q4 		$11.4M Sell
167,400
-1,555
-0.9% -$101K 1.02% 29
2020
Q3 		$9.87M Buy
168,955
+15,075
+10% +$938K 1.03% 28
2020
Q2 		$10M Sell
153,880
-4,000
-3% -$252K 1.04% 33
2020
Q1 		$9.37M Sell
157,880
-42,635
-21% -$2.85M 1.13% 31
2019
Q4 		$14.9M Sell
200,515
-11,000
-5% -$772K 1.32% 26
2019
Q3 		$13.3M Buy
+211,515
New +$12.5M 1.28% 27
2019
Q1 		– Sell
-4,300
Closed -$282K – 166
2018
Q4 		$282K Sell
4,300
-3,700
-46% -$276K 0.03% 147
2018
Q3 		$630K Sell
8,000
-6,000
-43% -$429K 0.06% 127
2018
Q2 		$901K Buy
+14,000
New +$923K 0.09% 107

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cumberland Partners's CVS Position: Q4 2024 in Review

Cumberland Partners sold out of CVS Health (CVS) in Q4 2024, closing a stake of 29,150 shares — an estimated $1.83M sold.

Cumberland Partners first reported a position in CVS in Q2 2018 and held it in 24 quarters. The position peaked at $14.9M in Q4 2019. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Cumberland Partners reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Cumberland Partners sold 29,150 CVS Health shares in Q4 2024, an estimated $1.83M.
  • Cumberland Partners first reported a position in CVS Health in Q2 2018 and held it in 24 quarters.
  • Cumberland Partners's CVS Health position peaked at $14.9M in Q4 2019.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Cumberland Partners's 13F filing for Q4 2024, filed 3 Feb 2025.